Cell-free DNA in sports medicine: implications for clinical laboratory medicine

Cell-free DNA in sports medicine: implications for clinical laboratory medicine

Physical activity can have a strong impact on the concentration of several promising candidate biomarkers, including cell-free DNA (cfDNA).

Bibliographic Details
Main Authors:	Neuberger Elmo W.I., Simon Perikles
Format:	Article
Language:	English
Published:	De Gruyter 2022-08-01
Series:	Journal of Laboratory Medicine
Subjects:	cell-free dna cfdna exercise liquid biopsy physical activity
Online Access:	https://doi.org/10.1515/labmed-2022-0027

Similar Items

Feasibility of Cell-Free DNA Measurement from the Earlobe during Physiological Exercise Testing
by: Nils Haller, et al.
Published: (2022-06-01)

Kinetics of Plasma Cell-Free DNA under a Highly Standardized and Controlled Stress Induction
by: Benedict Herhaus, et al.
Published: (2023-02-01)

Evaluation of commercial kits for isolation and bisulfite conversion of circulating cell-free tumor DNA from blood
by: Stine H. Kresse, et al.
Published: (2023-09-01)

New Perspectives on the Importance of Cell-Free DNA Biology
by: Abel J. Bronkhorst, et al.
Published: (2022-09-01)

Using cfDNA and ctDNA as Oncologic Markers: A Path to Clinical Validation
by: Jonathan Dao, et al.
Published: (2023-08-01)

Cell-Free DNA as a Biomarker at Diagnosis and Follow-Up in 256 B and T-Cell Lymphomas
by: Ramón Diez-Feijóo, et al.
Published: (2024-01-01)

Ultra Deep Sequencing of Circulating Cell-Free DNA as a Potential Tool for Hepatocellular Carcinoma Management
by: Mónica Higuera, et al.
Published: (2022-08-01)

Donor-Derived Cell-Free DNA in Kidney Transplantation as a Potential Rejection Biomarker: A Systematic Literature Review
by: Adrian Martuszewski, et al.
Published: (2021-01-01)

Detecting cancer from cell-free DNA sequencing fragmentation patterns
by: Chen, L
Published: (2023)

Cell-Free DNA: Hope and Potential Application in Cancer
by: Yan-yan Yan, et al.
Published: (2021-02-01)

Putative Origins of Cell-Free DNA in Humans: A Review of Active and Passive Nucleic Acid Release Mechanisms
by: Stefan Grabuschnig, et al.
Published: (2020-10-01)

IDH1 mutation is detectable in plasma cell-free DNA and is associated with survival outcome in glioma patients
by: Stefania Crucitta, et al.
Published: (2024-01-01)

Plasma cell-free DNA (cfDNA) as a predictive and prognostic marker in patients with metastatic breast cancer
by: Daniel Fernandez-Garcia, et al.
Published: (2019-12-01)

BL-MOL-AR Project, Preliminary Results about Liquid Biopsy: Molecular Approach Experience and Research Activity in Oncological Settings
by: Pancrazzi Pancrazzi, et al.
Published: (2023-09-01)

Reliability of Cell-Free DNA and Targeted NGS in Predicting Chromosomal Abnormalities of Patients With Myeloid Neoplasms
by: Andrew Ip, et al.
Published: (2022-06-01)

Liquid biopsy: New opportunities for precision medicine in hepatocellular carcinoma care
by: Inah Marie C. Aquino, et al.
Published: (2024-03-01)

Elevated brain-derived cell-free DNA among patients with first psychotic episode – a proof-of-concept study
by: Asael Lubotzky, et al.
Published: (2022-06-01)

Can Liquid Biopsy Based on ctDNA/cfDNA Replace Tissue Biopsy for the Precision Treatment of EGFR-Mutated NSCLC?
by: Yi-Ze Li, et al.
Published: (2023-02-01)

The Challenge to Stabilize, Extract and Analyze Urinary Cell-Free DNA (ucfDNA) during Clinical Routine
by: Ivonne Nel, et al.
Published: (2023-12-01)

Retrospective Evaluation of Somatic Alterations in Cell-Free DNA from Blood in Retinoblastoma
by: David H. Abramson, MD, et al.
Published: (2021-03-01)

Beyond the Blood: CSF-Derived cfDNA for Diagnosis and Characterization of CNS Tumors
by: Abbye E. McEwen, et al.
Published: (2020-02-01)

What fraction of cellular DNA turnover becomes cfDNA?
by: Ron Sender, et al.
Published: (2024-02-01)

Low-Coverage Whole Genome Sequencing of Cell-Free DNA From Immunosuppressed Cancer Patients Enables Tumor Fraction Determination and Reveals Relevant Copy Number Alterations
by: Amira Bouzidi, et al.
Published: (2021-08-01)

Deep cfDNA fragment end profiling enables cancer detection
by: Yulia V. Zhitnyuk, et al.
Published: (2022-01-01)

Extracellular Vesicle-Derived DNA vs. CfDNA as a Biomarker for the Detection of Colon Cancer
by: Kavita Thakur, et al.
Published: (2021-07-01)

The fragmentomic property of plasma cell-free DNA enables the non-invasive detection of diabetic nephropathy in patients with diabetes mellitus
by: Chaolun Yu, et al.
Published: (2023-10-01)

Utility of cfDNA Fragmentation Patterns in Designing the Liquid Biopsy Profiling Panels to Improve Their Sensitivity
by: Maxim Ivanov, et al.
Published: (2019-03-01)

cfDNA Changes in Maximal Exercises as a Sport Adaptation Predictor
by: Kinga Humińska-Lisowska, et al.
Published: (2021-08-01)

Multiplexed DNA Methylation Analysis in Colorectal Cancer Using Liquid Biopsy and Its Diagnostic and Predictive Value
by: Walter Pulverer, et al.
Published: (2021-10-01)

Detection of Cell Types Contributing to Cancer From Circulating, Cell-Free Methylated DNA
by: Megan E. Barefoot, et al.
Published: (2021-07-01)

Fragment size and level of cell-free DNA provide prognostic information in patients with advanced pancreatic cancer
by: Morten Lapin, et al.
Published: (2018-11-01)

The evidence base for circulating tumour DNA blood-based biomarkers for the early detection of cancer: a systematic mapping review
by: Ian A. Cree, et al.
Published: (2017-10-01)

Detection of ERBB2 (HER2) Gene Amplification Events in Cell-Free DNA and Response to Anti-HER2 Agents in a Large Asian Cancer Patient Cohort
by: Jeeyun Lee, et al.
Published: (2019-04-01)

Graft-Derived Cell-Free DNA Quantification following Liver Transplantation Using Tissue-Specific DNA Methylation and Donor-Specific Genotyping Techniques: An Orthogonal Comparison Study
by: Daniel R. A. Cox, et al.
Published: (2023-06-01)

Advances in the Detection of Pancreatic Cancer Through Liquid Biopsy
by: Tian-Bao Yan, et al.
Published: (2021-12-01)

Promoter hypermethylation of RARB and GSTP1 genes in plasma cell‐free DNA as breast cancer biomarkers in Peruvian women
by: Pierina Danos, et al.
Published: (2023-12-01)

Preoperative Mutational Analysis of Circulating Tumor Cells (CTCs) and Plasma-cfDNA Provides Complementary Information for Early Prediction of Relapse: A Pilot Study in Early-Stage Non-Small Cell Lung Cancer
by: A. N. Markou, et al.
Published: (2023-03-01)

Next Generation Sequencing-Based Profiling of Cell Free DNA in Patients with Advanced Non-Small Cell Lung Cancer: Advantages and Pitfalls
by: Riziero Esposito Abate, et al.
Published: (2020-12-01)

Clinical Potential of Circulating Cell-Free DNA (cfDNA) for Longitudinally Monitoring Clinical Outcomes in the First-Line Setting of Non-Small-Cell Lung Cancer (NSCLC): A Real-World Prospective Study
by: Valerio Gristina, et al.
Published: (2022-12-01)

Circulating Tumor DNA in Gastric and Gastroesophageal Junction Cancer
by: Lisa Paschold, et al.
Published: (2022-02-01)